CT Lung Nodule Assessment (LNA)
Assessing lung nodules over time
Enables review and analysis of thoracic CT images, providing segmentation, quantification and characterization of physician-indicated lung nodules. The application can be used in both diagnostic and screening evaluations, supporting Low Dose CT Lung Cancer Screening*
Benefits
- Automatic lung and lobes segmentation and one click 2D and 3D nodule segmentation.
- Supports LungRADS categorization, Fleischner Society guidelines for incidental findings as well as a Risk Calculator tool**.
- Pre-filled data including characteristics for each nodule in configurable presets are provided automatically by the application.
- Lung and nodule segmentations can be shared as RT Structures.
* The screening must be performed within the established inclusion criteria of programs/protocols that have been approved and published by either a governmental body or professional medical society. Please refer to clinical literature, including the results of the National Lung Screening Trial (N Engl J Med 2011; 365:395-409) and subsequent literature, for further information.
** Based on patient and nodule characteristics for estimation of the probability that lung nodules detected on baseline screening low-dose CT scans are malignant. These functionalities may not be available in all territories. Please contact a Philips representative for more details.
** Based on patient and nodule characteristics for estimation of the probability that lung nodules detected on baseline screening low-dose CT scans are malignant. These functionalities may not be available in all territories. Please contact a Philips representative for more details.